Fundz

Lanier Biotherapeutics, Inc. reported raising $805,000 in an initial SEC Form D filing, from an offering of $2 Million

PRIVATEAug 06, 2021$805K of $2M raised

Amount Raised

$805,000

$805,000 sold, per SEC Form D (first sale Aug 6, 2021)

Round Type

Seed

BogartBiotechnology

Quick answer

Lanier Biotherapeutics raised $805,000 in a Seed round, dated August 6, 2021. Lanier Biotherapeutics is based in Bogart, Georgia, United States.

How much did Lanier Biotherapeutics raise?
Lanier Biotherapeutics raised $805,000 in a Seed round on August 6, 2021.
What does Lanier Biotherapeutics do?
Lanier Biotherapeutics was founded by combining the businesses of Biophtha and Abeome, to further develop an existing first-in-class biologics portfolio for specialty disease, with the ultimate goal of improving the way..
Where is Lanier Biotherapeutics based and how big is it?
Lanier Biotherapeutics is based in Bogart, Georgia, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Lanier Biotherapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Neochord raised $1M (Seed) on September 20, 2021.
  • Varda Space Industries raised $42M on September 20, 2021.
  • Allay Therapeutics raised $87M on September 20, 2021.
  • Ventyx Biosciences raised $51M on September 20, 2021.
  • Biolinq raised $62M on September 17, 2021.
  • Enkefalos Biosciences, Inc. raised $1.5M (Seed) on September 17, 2021.

Who to call at Lanier Biotherapeutics, and when

A new round usually means Lanier Biotherapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Lanier Biotherapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Lanier Biotherapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Lanier Biotherapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Lanier Biotherapeutics

Location

150 BEN BURTON ROAD

Bogart, Georgia, United States

About

Lanier Biotherapeutics was founded by combining the businesses of Biophtha and Abeome, to further develop an existing first-in-class biologics portfolio for specialty disease, with the ultimate goal of improving the way we survive, age, and live. Lanier targets four major verticals: Multi-functional Retina, Type 2 Inflammation, Dermatology, and ImmunoOncology. Lanier’s lead developments programs include LNR 653.1, a fully humanized anti-VEGF / IL-17A multifunctional antibody for the treatment of retinal neovascularization diseases and LNR 125.36, a fully humanized anti-IL-25 monoclonal antibody for the treatment of Type 2 Inflammatory diseases.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Lanier Biotherapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Lanier Biotherapeutics's next move

See what Strategic adds

Lanier Biotherapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.